Posted in | News | Imaging

Researchers Use Magnetic Resonance Imaging to Study Cerebral Leukoaraiosis

According to analysts at the Mayo Clinic, leukoaraiosis, a common condition wherein miniscule areas of the brain that have been denied oxygen and manifest as white dots in MRI scans, is not a harmless component of ageing but a disease that changes the brain function in the aged. The online version of the journal Radiology has published the study results.

Leukoaraiosis is also known as small vessel ischemia and called unidentified bright objects or ¡§UBOs¡¨ on the brain scan. It occurs when diseased blood vessels result in small regions of damage in the brain¡¦s white matter. The lesions are seen often in persons over 60 years and the magnitude of the disease differs among persons affected.

Dr. Kirk M. Welker, assistant professor of radiology in the College of Medicine at the Mayo Clinic at Rochester, Minn, feels that earlier leukoaraiosis was only identified as a normal component of ageing similar to wrinkles and gray hair. Now it is identified as a disease which is believed to be precipitated by high blood pressure and whose risk increases with aging. Recognizing the disease is vital for patients being treated as well as for research. He pointed out that brain white matter deterioration affects linkage with the brain¡¦s language network, thus diminishing the network function.

Dr. Welker¡¦s group conducted functional MRI scans on persons with normal cognition selected from the Mayo Clinic Study of Aging during 2006ƒ{2010. In 18 persons, the leukoaraiosis was a modest 25 ml and in 18 age-matched controls it was below 5 ml. MRI scans of the patients were taken as they performed a linguistic decision-making assignment of identifying word pairs and an assignment of visual perception entailing distinguishing between straight and diagonal lines. Patients with moderate leukoaraiosis had anomalous brain activation patterns compared to those in the control group.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 27). Researchers Use Magnetic Resonance Imaging to Study Cerebral Leukoaraiosis. AZoOptics. Retrieved on November 23, 2024 from https://www.azooptics.com/News.aspx?newsID=15961.

  • MLA

    Thomas, G.P.. "Researchers Use Magnetic Resonance Imaging to Study Cerebral Leukoaraiosis". AZoOptics. 23 November 2024. <https://www.azooptics.com/News.aspx?newsID=15961>.

  • Chicago

    Thomas, G.P.. "Researchers Use Magnetic Resonance Imaging to Study Cerebral Leukoaraiosis". AZoOptics. https://www.azooptics.com/News.aspx?newsID=15961. (accessed November 23, 2024).

  • Harvard

    Thomas, G.P.. 2019. Researchers Use Magnetic Resonance Imaging to Study Cerebral Leukoaraiosis. AZoOptics, viewed 23 November 2024, https://www.azooptics.com/News.aspx?newsID=15961.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.